drugset / Trial / NCT00352118

Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

NCT00352118 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as docetaxel, cisplatin, and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving combination chemotherapy together with radiation therapy may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving combination chemotherapy together with radiation therapy works in treating patients with locally advanced head and neck cancer. The doctor also wants to find out if patients who receive this treatment need a feeding tube 1 year after starting treatment.

Timeline

Start
2006-03
Primary completion
2008-04
Completion
2008-04

Outcome

Outcome not reported

Stopped: “Low dose radiation treatment was not appropriate for these patients.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — Intravenous
Subject Docetaxel Small molecule — Intravenous
Subject fluorouracil Small molecule — Intravenous
Background Pegfilgrastim Protein / enzyme biologic — Subcutaneous
Background filgrastim Protein / enzyme biologic — Subcutaneous

Indications